Research Article

Prognostic Implications of ALDH1 and Notch1 in Different Subtypes of Oral Cancer

Table 2

Association between clinicopathological variables and ALDH1 immunoexpression in patients with subtypes of oral cancer.

VariableALDH1 immunoexpression in subtypes of oral cancer
WDOSCCpPDOSCCpBSCCp
(−)(+)(−)(+)(−)(+)
N (%)N (%)N (%)N (%)N (%)N (%)

Gender
Male9 (50.0)2 (100)0.4799 (75.0)5 (100)0.5159 (90.0)7 (77.3)0.582
Female9 (50.0)03 (25.0)01 (10.0)2 (22.2)

Age
≤60 years8 (44.4)2 (100)0.4747 (58.3)4 (80.0)0.6004 (40.0)2 (22.2)0.628
>60 years10 (55.8)05 (41.7)1 (20.0)6 (60.0)7 (77.8)

Tobacco
Yes6 (75.0)2 (100)1.0006 (85.7)5 (100)1.0006 (85.7)6 (100)1.000
No2 (25.0)01 (14.3)01 (14.3)0

Alcohol
Yes5 (55.6)2 (100)0.4916 (100)5 (100)NC4 (66.7)5 (83.3)1.000
No4 (44.4)0002 (33.8)1 (16.7)

T stage
T1-T210 (55.6)1 (50.0)1.0001 (8.3)1 (20.0)0.5154 (40.0)2 (22.2)0.628
T3-T48 (44.4)1 (50.0)11 (91.7)4 (80.0)6 (60.0)7 (77.8)

N stage
N014 (77.8)2 (100)1.0004 (33.3)1 (20.0)1.0004 (44.4)1 (11.1)0.294
N+4 (22.2)08 (66.7)4 (80.0)5 (55.6)8 (88.9)

Radiotherapy
Yes4 (22.2)2 (100)0.07910 (83.3)4 (80.0)1.0006 (60.0)8 (88.9)0.303
No14 (77.8)02 (16.7)1 (20.0)4 (40.0)1 (11.1)

Recurrence
Yes7 (38.9)00.5215 (41.7)3 (60.0)0.6207 (70.0)6 (66.7)1.000
No11 (61.1)2 (100)7 (58.3)2 (40.0)3 (30.0)3 (33.3)

Angiolymphatic invasion
Yes3 (17.6)01.0002 (18.2)1 (20.0)1.0003 (30.0)4 (44.4)0.650
No14 (82.5)2 (100)9 (81.8)4 (80.0)7 (70.0)5 (55.6)

Perineural infiltration
Yes8 (47.1)1 (50.0)1.0008 (72.7)2 (40.0)0.2994 (44.4)1 (11.1)0.294
No9 (52.9)1 (50.0)3 (27.3)3 (60.0)5 (55.6)8 (88.9)

Lymph node (pN)
Yes3 (25.0)01.0008 (66.7)3 (75.0)1.0005 (62.5)6 (66.7)1.000
No9 (75.0)2 (100.0)4 (33.3)1 (25.0)3 (37.5)3 (33.3)

WDOSCC, well-differentiated oral squamous cell carcinoma; PDOSCC, poorly differentiated squamous cell carcinoma; BSCC, basaloid squamous cell carcinoma; N, number of tumors; NC, not calculated. Analysis by chi-square test or Fischer’s exact test.  < 0.05 was considered statistically significant. Excluded patients without records.